Partner Headlines - BIIB

  1. Alert: Alzheimer’s Drug Fails In Clinical Trial - Stocks Sink

    TalkMarkets
  2. Dow Jones Industrial Average Hits New Record In Afternoon Trading ...

    TalkMarkets
  3. Paid To Wait? Eli Lilly Crashes To 2 Year Lows, Erases 6 Years ...

    TalkMarkets
  4. Morgan Stanley Expects Big Reversal Today In Biogen Shares

    TalkMarkets
  5. Magic Recipe Movers - The Trump Effect

    TalkMarkets
  6. On The Fly: Top stock stories for Monday

    TalkMarkets
  7. Biogen Rises After Muscular Disorder Drug Data, Piper Upgrade ...

    TalkMarkets
  8. Morning Call For Monday, Nov. 7

    TalkMarkets
  9. Biogen Upgraded To Overweight From Neutral At Piper Jaffray

    TalkMarkets
  10. Fundamentals Remain Strong In The Pharma Sector

    TalkMarkets
  11. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets
  12. Biotech Stock Roundup: Clinical Holds Hit Inovio & Aduro, Vertex ...

    TalkMarkets
  13. 5 Stocks To Watch Before The Market Opens Tomorrow (October 26, ...

    TalkMarkets
  14. 7 Drug Stocks To Consider As Biosimilars Pick Up Pace

    TalkMarkets
  15. Biotech Stock Roundup: Ariad Down On Drug Pricing Tweet, Regeneron ...

    TalkMarkets
  16. Fed Minutes Show Conflicted Central Bank

    TalkMarkets
  17. Biotech Stock Roundup: Alnylam Slumps On Revusiran Update, TESARO ...

    TalkMarkets
  18. Bristol-Myers Falls As Merck Upstages With New Lung Cancer Data

    TalkMarkets
  19. Earnings ESP

    TalkMarkets
  20. Biotech ETFs Lead Q3 Rally: XBI Breaks Out

    TalkMarkets
  21. Stock Indexes Mostly Flat; Time Warner Rises; Tesla Earnings ...

    Investors Business Daily
  22. 2 Biotech Funds Leading Nascent Bull Market: Which Is Right For ...

    Investors Business Daily
  23. Biogen Stock Pops As Merck, Allergan Reportedly Probing Buyout

    Investors Business Daily
  24. QQQ ETF Posts 52-Week High; Energy Stocks Sag As Oil Drops To ...

    Investors Business Daily
  25. Nasdaq Ends Near Record High; Oil Stocks Sink Dow, S&P 500

    Investors Business Daily
  26. What's Driving The Biotech Stock Rally? And Will It Last?

    Investors Business Daily
  27. Indexes Mixed As Oil Stocks Tumble; Alphabet Near High

    Investors Business Daily
  28. Nasdaq Poised To Surpass 5200; Other Indexes Lag On Oil Stock ...

    Investors Business Daily
  29. Are Biotechs Finally Making A Comeback? Here Are 5 Must-Watch ...

    Investors Business Daily
  30. Ionis, Biogen Score Surprise Win Against Childhood Spinal Disease

    Investors Business Daily
  31. Stocks Open Narrowly Mixed; SolarCity Falls On Tesla Deal

    Investors Business Daily
  32. This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or ...

    Investors Business Daily
  33. SPY ETF Posts Fourth Weekly Gain As Chip And Biotech Giants Surge

    Investors Business Daily
  34. Week In Review: Stock Breakouts, Netflix Subs Snub, Tesla's Plan, ...

    Investors Business Daily
  35. Stocks Down At Midday; Biogen Leads Biotech Rebound

    Investors Business Daily
  36. Biogen CEO Quits Amid M&A Speculation; Company Hikes Outlook

    Investors Business Daily
  37. Investing Action Plan: Starbucks, AT&T, Chipotle, Biogen, Visa, ...

    Investors Business Daily
  38. John Paulson Bulks Up Health Care Bet

    GuruFocus
  39. Gilead, Johnson & Johnson or Roche?

    GuruFocus
  40. Jeff Auxier Takes Plunge in Fastenal, a Stock From Watchlist ...

    GuruFocus
  41. Biotech Stocks Slip As Hugely Popular Momentum ETF Makes A Big ...

    IBD
  42. Former Leaders Show Up On New Low List; D.R. Horton Sinks Again

    IBD
  43. Nike To Facebook: Frank Caruso Projects Long-Term Earnings Growth

    IBD
  44. LinkedIn Downgraded; Biotechs Initiated; Tableau PT Cut

    IBD
  45. Maybe Some Good News For A Big Biotech ETF

    Benzinga
  46. Sobi to present new interim ASPIRE data at EAHAD congress suggesting ...

    Benzinga
  47. Earnings Recap For January 27

    Benzinga
  48. Apple and Boeing Earnings, Plus Oil Drag, Combine to Dent Stocks

    Benzinga
  49. Biogen's Stock Pops Following Better-Than-Expected Q4 Results

    Benzinga
  50. 10 Stocks Moving In Wednesday's Pre-Market Session

    Benzinga
  51. Earnings Scheduled For January 27, 2016

    Benzinga
  52. Big Earnings Expectations For Big Biotech

    Benzinga
  53. Biogen Ticks Up Following EU Marketing Authorization Of Benepali

    Benzinga
  54. Biogen, Samsung JV Announces Etanercept Biosimilar Referencing ...

    Benzinga
  55. Stocks Reverse Higher To Big Gains; Intel Falls After Q4 Results

    IBD
  56. This Week Is Paramount For Biotech Stocks

    Benzinga
  57. Richard Snow Makes Huge Increases in Big-Name Stocks

    GuruFocus
  58. Jean Hynes Finds Her Pot of Gold

    GuruFocus
  59. Jim Cramer Gives His Opinion On Lockheed Martin And Gilead Sciences

    Benzinga
  60. Not All Of Clinton's Policies Are Bad For Pharmaceuticals

    Benzinga
  61. GoPro Downgraded, Ambarella PT Cut, Biotechs Are Buys

    IBD
  62. Early Global News: Virtual Reality Market Getting Really Big, ...

    Benzinga
  63. Sanofi chips at Biogen share

    IBD
  64. Sanofi Chipping Away At Biogen's MS Dominance

    IBD
  65. Biotechs Weaken, But These Names Have Bullish Charts

    IBD
  66. Sobi and Biogen's Elocta Approved by EC for Treatment of Haemophilia ...

    Benzinga
  67. Stocks Quietly Higher; JD.com Clears Key Resistance

    IBD
  68. PRIMECAP Sells Stake in Technology Company

    GuruFocus
  69. Vanguard Raises Stakes in Biogen, Mylan, Merck

    GuruFocus
  70. Biogen Among Murray Stahl's Holdings With Growing Earnings

    GuruFocus
  71. 10 S&P 500 Companies With Green Operations

    Benzinga
  72. Roche Touts New MS Drug As Legacy Players Hit Snags

    IBD
  73. Biogen's Breach Of 50-Day Line Was Clear Sell Signal

    IBD
  74. Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer

    GuruFocus
  75. Biotechs Among Stocks That Insiders Have Been Buying Lately

    Benzinga
  76. Biogen Is a Bargain

    GuruFocus
  77. Wild Short Interest Swings For Three Top Biotech Stocks

    Benzinga
  78. Apple Upgraded To Buy; Amazon, McDonald's PTs Hiked

    IBD
  79. Hurricane Hillary Shifts Left, Slamming More Stocks

    IBD
  80. Biogen tops Q3, will cut jobs

    IBD
  81. Biogen Volatile After Q3 Beat, Raised Guidance And Disappointing ...

    Benzinga
  82. Why Biogen Stock Is Having A Huge Day

    Benzinga
  83. Biogen Beats Q3 Views, Cuts Workforce, Lifts Guidance

    IBD
  84. Early Gains Fizzle, Turn Mixed; Biogen, Ferrari Rise

    IBD
  85. Benzinga's Top #PreMarket Gainers

    Benzinga
  86. Earnings Scheduled For October 21, 2015

    Benzinga
  87. Fast Money Picks For October 20

    Benzinga
  88. Stock Week Ahead: Housing Data, Broad-Based Earnings Line Up

    Benzinga
  89. Why Rental Rates At Biotech Labs Are Skyrocketing

    IBD
  90. Valeant Subpoenaed By Federal Prosecutors On Pricing

    IBD
  91. Valeant Subpoenaed By Federal Prosecutors On Pricing

    IBD
  92. Market Has Overreacted in Biogen

    GuruFocus
  93. Frank Sands' Undervalued Holdings With Growing EPS

    GuruFocus
  94. Warren Buffett Not Top 100 CEO; Ex VW CEO Is No. 20

    IBD
  95. Stocks Inch Up; Oil Gains Ease; Alcoa, Tesla, Gap Stumble

    IBD
  96. Gilead, Biotechs Were TPP Losers; Boeing Is Upbeat

    IBD
  97. Biotechs, Medicals Whacked As Nasdaq Trades Near Day's Low

    IBD
  98. Will Fund Managers Pump Up Edwards To New Breakout?

    IBD
  99. DuPont Cushions Dow; Chip Stocks, Biotechs Weigh On Nasdaq

    IBD
  100. Trans Pacific Trade Pact Finally Agreed

    Benzinga
Trading Center